Theme Day Commercialization of Medicine - Erik Penser Bank
Oncopeptides CFO Anders Martin-Löf presents at Erik Penser Bank's theme day Commercialization of medical component on May 6 at 16:15 CET. The theme day is broadcast live 09: 00-17: 00 CET. Welcome to listen to the presentation via the link below.
June 23, 2022, the European Medicines Agency´s (EMA) Committee for Medicinal Products for Human Use (CHMP), has unanimously adopted a positive opinion recommending a full marketing authorization approval (MAA) of Pepaxti® (melphalan flufenamide, also called melflufen) in EU.
The Annual General Meeting in Oncopeptides AB (publ) will be held on Tuesday June 28, 2022, (changed from May 19, 2022) in Stockholm, Sweden. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence.